Zydus Lifesciences announced that the U.S. Food and Drug Administration (USFDA) has granted Fast Track Designation to Usnoflast (ZYIL1), a novel oral NLRP3 inhibitor, for the treatment of Amyotrophic ...

Those with ALS have an average survival of around two to five years from diagnosis, with most ALS patients dying from ...

Sagar Doshi of Nuvama Professional Clients Group recommends these three stocks today - Chennai Petroleum Corporation Ltd, ...

Ahmedabad: Zydus, a discovery-based, global pharmaceutical company, has announced that the USFDA has granted ‘Fast Track ...

IIM Ahmedabad has received funds worth Rs 12 crore for inflation-linked scholarships, with the amount adjusted regularly to maintain its value over time.

IST, the barometer index, the S&P BSE Sensex, slipped 150.18 points or 0.18% to 81,398.36. The Nifty 50 index shed 52.85 points or 0.21% to 24,776.35.

The Nifty Pharma index closed on a negative note on Wednesday. Shares of Ipca Laboratories Ltd.(up 2.42 per cent), Laurus ...

AM(IST)on Wednesday in a weak market. Laurus Labs Ltd.(up 2.51 per cent), Zydus Lifesciences Ltd.(up 0.6 per cent), Ajanta ...

The scholarship is a tribute to Professor Jaswant G Krishnayya, a former faculty member at IIMA who had a big influence on ...